COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 1836: Articles 18351-18360  | Next

High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19
Ko, S. H., Bayat Mokhtari, E., Mudvari, P., Stein, S., Stringham, C. D., Wagner, D., Ramelli, S., Ramirez-Benitez, M. J., Strich, J. R., Davey, R. T., Zhou, T., Misasi, J., Kwong, P. D., Chertow, D. S., Sullivan, N. J., Boritz, E. A.
10.1101/2021.02.21.432184 — Posted: 2021-02-22
The interspecific fungal hybrid Verticillium longisporum displays sub-genome-specific gene expression
Depotter, J., van Beveren, F., Rodriguez-Moreno, L., Kramer, M., Chavarro Carrero, E., Lorencini Fiorin, G., van den Berg, G., Wood, T., Thomma, B., Seidl, M.
10.1101/341636 — Posted: 2021-02-22
An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19
Wang, J. Y., Zhang, W., Roehrl, M. W., Roehrl, V. B., Roehrl, M. H.
10.1101/2021.02.21.432171 — Posted: 2021-02-22
Laser-facilitated epicutaneous immunization with SARS-CoV-2 spike protein induces ACE2 blocking antibodies in mice
Scheiblhofer, S., Drother, S., Braun, W., Braun, R., Boesch, M., Weiss, R.
10.1101/2021.02.22.432259 — Posted: 2021-02-22
SARS-CoV-2 B.1.1.7 and B.1.351 Spike variants bind human ACE2 with increased affinity
Khavari, P., Ramanathan, M., Ferguson, I. D., Miao, W.
10.1101/2021.02.22.432359 — Posted: 2021-02-22
Nanoceutical Fabric Prevents COVID-19 Spread through Expelled Respiratory Droplets: A Combined Computational, Spectroscopic and Anti-microbial Study
Adhikari, A., Pal, U., Bayan, S., Mondal, S., Ghosh, R., Darbar, S., Saha-Dasgupta, T., Ray, S. K., Pal, S. K.
10.1101/2021.02.20.432081 — Posted: 2021-02-22
Effectiveness of Non-Pharmaceutical Interventions on Child and Staff COVID-19 Cases in US Summer Camps
Suh, H. H., Blaisdell, L., Meehan, J., Browne, L.
10.1101/2021.02.18.21250271 — Posted: 2021-02-22
What is the extent of COVID-19 vaccine hesitancy in Bangladesh? : A cross-sectional rapid national survey
Ali, M., Hossain, A.
10.1101/2021.02.17.21251917 — Posted: 2021-02-22 Discussion: Onsite
Methodological Approach for Wastewater Based Epidemiological Studies for SARS-CoV-2
Kopperi, H., Tharak, A., Hemalatha, M., Kiran, U., Gokulan, C. G., Mishra, R. K., Venkata Mohan, S.
10.1101/2021.02.17.21251905 — Posted: 2021-02-22 Discussion: Onsite
Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition
Liu, X., Verma, A., Ramage, H., Garcia, G., Myers, R. L., Lucas, A., Michaelson, J. J., Coryell, W., Kumar, A., Charney, A., Kazanietz, M. G., Rader, D. J., Ritchie, M. D., Berrettini, W. H., Damoiseaux, R., Arumugaswami, V., Schultz, D., Cherry, S., Klein, P. S.
10.1101/2021.02.17.21251933 — Posted: 2021-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).